ArticleCureus2025
Frailty-Adjusted Inpatient Glycaemic Targets for Preventing Hypoglycaemia: A Quality Improvement Project.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOlder adults with frailty are particularly vulnerable to harm from tight glycaemic control, with hypoglycaemia contributing to falls, cognitive decline, and increased mortality. National (JBDS: Inpatient Care of the Frail Older Adult with Diabetes) and local (Buckinghamshire, Oxfordshire & Berkshire-BOB) guidelines recommend individualising glucose targets according to frailty level, but adherence is inconsistent. This quality improvement project evaluated glycaemic management in inpatients with frailty, aiming to reduce hypoglycaemia and improve target setting in line with frailty status. METHODOLOGY: A two-cycle quality improvement project was conducted across four elderly-care wards at the Royal Berkshire Hospital. The inclusion criteria included patients aged ≥65 years with a diagnosis of either Type 1 or Type 2 diabetes who experienced one or more hypoglycaemic episodes (<4 mmol/L) during their admission. Ward-level hypoglycaemia incidence was calculated as the proportion of all elderly-care inpatients aged ≥65 with diabetes who experienced at least one hypoglycaemic episode during each cycle. Further analyses were performed only within the cohort of patients who experienced hypoglycaemia. Cycle 1 (January to March 2025) included 31 patients meeting these criteria out of 209 elderly-care inpatients aged ≥65 with diabetes (15%). Cycle 2 (May to July 2025) included 12 out of 202 patients (6%) following staff education and reinforcement of local hypoglycaemia management guidelines. Frailty was assessed using the Clinical Frailty Scale (CFS), and glucose targets were set according to frailty category. Data from Diabetes Specialist Nurse referrals and incident reports were analysed in both cycles to assess hypoglycaemia rates, documentation of glucose targets, and medication adjustments.
resultsBetween cycles, the incidence of hypoglycaemia in elderly inpatients with diabetes decreased by 60% (from 15% to 6%). Among those who experienced hypoglycaemia, the proportion with frequent episodes (≥3 episodes) fell by 10% (from 77% to 67%). The incidence of significant hypoglycaemia (≤3 mmol/L) remained unchanged at 58%. Among patients with a CFS of 7-9, correct glucose target documentation improved substantially, rising from 25% to 80%. In contrast, documentation fell from 56% to 20% in those with a CFS of four to six, showing variability in practice. Proactive medication optimisation, such as insulin de-escalation and adjustment of oral hypoglycaemic agents, was carried out more consistently in Cycle 2.
conclusionsFrailty-adjusted glycaemic targets and proactive medication review can markedly reduce hypoglycaemia in older adults with frailty during their admission. Sustaining improvements will require ongoing staff education, standardised pathways, and clear documentation to ensure safer diabetes management in this vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.